Tc-99m sestamibi defect magnitude predicts the amount of viable myocardium after coronary reperfusion despite the presence of severe residual stenosis

Journal of Nuclear Cardiology

Volumn 8, Issue 1, 2001, Pages 40-48

  Takehana, K ^a   Ruiz, M ^a   Petruzella, F D ^a   Watson, D D ^a   Beller, G A ^a   Glover, D K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Myocardial viability; Techetium 99m sestamibi

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TRIPHENYLTETRAZOLIUM;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; CORONARY REPERFUSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOG; FLOW RATE; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; IMAGE ANALYSIS; IN VITRO STUDY; INJECTION; ISOTOPE LABELING; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MEASUREMENT; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RISK;

EID: 0035087713     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2001.110387     Document Type: Article

References (32)

1. Can technetium 99m-labeled sestamibi track myocardial viability?
2. Quantification of myocardial infarction during coronary occlusion and myocardial salvage after reperfusion using cardiac imaging with technetium-99m hexakis 2-methoxyisobutyl isonitrile
3. Effect of ischemia and postischemic dysfunction on myocardial uptake of technetium-99m-labeled methoxyisobutyl isonitrile and thallium-201
4. Are the kinetics of technetium-99m methoxyisobutyl isonitrile affected by cell metabolism and viability?
5. Quantification of area at risk during coronary occlusion and degree of myocardial salvage after reperfusion with technetium-99m methoxyisobutyl isonitrile
6. 99mTc-SESTAMIBI in cultured chick ventricular myocytes during ATP depletion
7. Technetium-99m-sestamibi uptake and retention during myocardial ischemia and reperfusion
8. Predicting recovery of severe regional ventricular dysfunction: Comparison of resting scintigraphy with thallium-201 and technetium-99m-sestamibi
9. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: Comparison with fluorine-18-FDG PET
10. Left ventricular dysfunction in coronary artery disease: Comparison between rest-redistribution thallium 201 and resting technetium 99m methoxy-isobutyl isonitrile cardiac imaging
11. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: Correlation with histologic and positron emission tomography studies and functional follow-up
12. 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function
13. Detecting myocardial salvage after primary PTCA: Early myocardial contrast echocardiography versus delayed sestamibi perfusion imaging
14. 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity
15. 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: Implications for dobutamine stress testing
16. Doppler measurement of myocardial thickening with a single epicardial transducer
17. Validation of a single crystal for measurement of transmural and epicardial thickening
18. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction
19. 201Tl and myocardial blood flow
20. Blood flow measurements with radionuclide-labeled particles
21. Position emission tomography detects evidence of viability in rest technetium-99m sestamibi defects
22. The role of sestamibi scintigraphy in the radioisotopic assessment of myocardial viability
23. Value of rest thallium-201/technetium-99m sestamibi scans and dobutamine echocardiography for detecting myocardial viability
24. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability
25. Identification of viable myocardium in patients with chronic coronary artery disease: Comparison of thalium-201 scintigraphy with rejection and technetium-99m-methoxyisobutyl
26. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction
27. 18F] fluorodeoxyglucose
28. 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study
29. Serial changes in myocardial perfusion using tomographic technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging following reperfusion therapy of myocardial infarction
30. Temporal relation between neutrophil accumulation and myocardial reperfusion injury
31. Progress impairment of regional myocardial perfusion after initial restoration of postischemic blood flow
32. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction